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Background/Aims: The role of uncoupling protein-2 (UCP2) 
in the liver is currently unclear. Emerging evidence suggests 
a relationship between UCP2 and oxidative stress. In the 
present study, we tested the hypothesis that UCP2 expres-
sion in the liver might change during warm ischemia-reperfu-
sion (I/R) according to oxidative stress. Methods: Wistar rats 
were subjected to 40 (short ischemia) or 90 (long ischemia) 
minutes of partial lobar ischemia followed by 4 hours of re-
perfusion. UCP2 expression in the ischemic and nonischemic 
lobes was assessed using reverse transcription-polymerase 
chain reaction and immunohistochemistry. Malondialdehyde 
concentrations in the liver tissue were also compared. Re-
sults: Malondialdehyde concentrations in the ischemic lobes 
were significantly higher in the long ischemia group. In the 
ischemic lobes of the short ischemia group, UCP2 protein ex-
pression was induced in hepatocytes, which did not express 
the protein prior to treatment, and the expression levels 
were higher than in the long ischemia group. The intralobular 
distribution of UCP2 seemed to correlate inversely with that 
of the necrotic area. UCP2 expression was observed, even 
in nonischemic lobes with similar intralobular heterogeneity. 
Conclusions: UCP2 was induced in hepatocytes after warm 
I/R. Although the primitive role of UCP2 expression may be 
cytoprotective in nature, its actual protective effect in hepatic 
I/R may be minimal. (Gut Liver 2011;5:486-492)
Key Words: Oxidative stress; Ischemia-reperfusion; Uncou-
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INTRODUCTION
The mechanism of tissue injury by hepatic ischemia-reperfusion 
(I/R) is thought to involve oxygen-derived free radicals.
1-3 
The antioxidant status of the tissue affected by I/R is of great 
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importance for the primary endogenous defense against free 
radical-induced injury. Under normal physiological conditions, 
cells have developed multiple, complementary mechanisms to 
minimize oxidative damage, including the induction of oxidant 
detoxifying enzymes, such as superoxide dismutase, and the ac-
cumulation of oxidant buffers, such as reduced glutathione.
4,5 A 
better understanding of these molecular pathophysiology of I/R 
injury in liver surgery will aid in the design of advanced thera-
peutic strategies.
The uncoupling protein 2 (UCP2) is integral membrane pro-
tein of the mitochondrial inner membrane, where they function 
as a proton channel or shuttle.
6,7 The gene UCP2 belongs to a 
family of genes found in animals and plants, encoding a pro-
tein homologous to the brown fat uncoupling protein UCP1.
8 
The common characteristic of these proteins is to uncouple the 
respiratory chain from ATP synthesis by dissipating the proton 
electrochemical gradient. Accordingly, these proteins have been 
implicated mainly in the maintenance of metabolic rate and 
adaptational thermoregulation.
6,9 However, the diversity of their 
possible biological roles is illustrated by the paper describing the 
enhanced ability of UCP2 knock-out mouse to destroy intracel-
lular pathogens due to alterations in the formation of reactive 
oxygen species (ROS), suggesting that UCP2 is related to the 
regulation of ROS production.
10,11 Furthermore, recent reports 
have revealed that an abundance of these proteins is modulated 
by several physiological conditions, suggesting that these pro-
teins are involved in metabolic adaptations.
10,12-14 In contrast 
to UCP1, which is considered specific to brown adipocytes, 
UCP2 has been detected in a large spectrum of tissues.
7,15 In the 
healthy liver, UCP2 messenger RNA (mRNA) was identified in 
Kupffer cells, but not in hepatocytes.
16 Chavin et al.
17 reported 
that the expression of UCP2 mRNA in hepatocytes is increased 
in genetically obese mice and induction of UCP2 protein con-
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electron transport chain, and provide an advantage by con-
straining mitochondrial ROS production.
Given the published evidence that UCP2 can modulate their 
abundance in response to a variety of stimuli and environmen-
tal conditions, we speculated that UCP2 expression in the liver 
might alter during warm I/R, in which mitochondrial oxidant 
production increases. The aim of the present study was to test 
this hypothesis and to evaluate the implications of altered UCP2 
expression after hepatic I/R.
MATERIALS AND METHODS
1. Animals
Inbred male Wistar rats (250 to 280 g) were purchased from 
Kyudo (Fukuoka, Japan), housed in temperature- and light-
controlled environmental conditions with a 12-hour light and 
dark cycle, and permitted ad libitum consumption of water 
and standard pellet chow. The Kyushu University Institutional 
Animal Care and Use Committee approved all animal protocols, 
according to the criteria outlined in the Guide for the Care and 
Use of Laboratory Animals prepared by the National Institutes 
of Health (NIH).
2. Operative procedure
All animals were anesthetized with intraperitoneal pentobar-
bital 50 mg/kg.  Laparotomy was carried out through a midline 
incision. Forty minutes (Short ischemia group; n=14) or 90 min-
utes (Long ischemia group; n=14) of warm hepatic ischemia was 
induced in the median and left lateral hepatic lobes by clamping 
the corresponding hepatic arterial and portal venous branches.
18 
The remaining lobes retained an intact portal and arterial blood 
supply, as well as venous drainage, preventing intestinal venous 
hypertension and bacterial translocation. When the assigned 
period of warm ischemia was completed, the microvascular clip 
was released and the abdomen was closed. Nonischemic lobes 
were not excised after reperfusion to allow comparison of the 
UCP2 expression on ischemic and nonischemic lobes separately. 
Sham animals (n=8) were treated in an identical fashion with 
the omission of vascular occlusion. The animals were sacrificed 
at 4 hours after reperfusion. Blood samples were drawn from 
abdominal aorta, and serum alanine aminotransferase (ALT) 
levels were assayed using standard enzymatic methods. Liver 
samples were excised before ischemia and 4 hours after reperfu-
sion. The specimens were immersed in liquid nitrogen immedi-
ately after sampling. Another tissue samples were fixed in 10% 
neutral buffered formalin.
3. Determination of malondialdehyde levels in the liver tis-
sue
The hepatic levels of malondialdehyde (MDA) after 4 hours 
of reperfusion were determined using a commercially available 
kit (Lipid Peroxidation Assay Kit; Calbiochem, San Diego, CA, 
USA) as described previously.
2 Protein concentrations were de-
termined using a Bio-Rad protein assay kit.
4. Histologic and immunohistochemical examinations
Formalin-fixed liver specimens were embedded in paraffin. 
Sections 3 μm thick were stained with hematoxylin and eosin 
(H&E) for histologic evaluation by light microscopy. For im-
munohistochemical detection of UCP2, the avidin-biotin peroxi-
dase complex method was used. The liver sections obtained at 4 
hours after reperfusion were deparaffinized and incubated at 4
oC 
overnight with primary goat antisera (1:50, v/v) to a conserved 
peptide sequence in murine and human UCP2 (Santa Cruz Bio-
technology Inc., Santa Cruz, CA, USA). The secondary biotinyl-
ated rabbit antigoat antibody and peroxidase-conjugated strep-
toavidin were from a Histofine SAB-PO (G) kit (Nichirei, Tokyo, 
Japan). After staining with diaminobenzidine, the slides were 
counterstained with hematoxylin, dehydrated and mounted. As 
negative controls, sections exposed to nonimmune antisera were 
included in each assay to assure specificity.
Four hours after reperfusion, the extent of UCP2 immuno-
reactivity was semi-quantitatively assessed in 10 random high 
power fields of ischemic and nonischemic lobes as follows: 
none, 0; up to 30%, 1; up to 60%, 2; more than 60%, 3. These 
scores were averaged and compared. All sections were exam-
ined by the same investigator (T.T.), who did not know the as-
signment of specimens to a particular group of rats.
5. RNA extraction and semi-quantitative reverse transcrip-
tion-polymerase chain reaction (RT-PCR)
Total RNA was extracted from frozen liver tissue using com-
mercially available kits (QIAGEN RNeasy Mini Kit; QIAGEN 
GmbH, Hilden, Germany). RNA was quantified by spectroscopy 
and its quality was evaluated by agarose gel electrophoresis and 
subsequent ethidium bromide staining. Synthesis of the first 
strand cDNA was done with 2.0 μg of total RNA using a First-
Strand cDNA Synthesis Kit (Amersham Pharmacia Biotech, Am-
ersham, UK) according to manufacturer’s protocol.
The levels of UCP2 mRNA extracted from liver were analyzed 
by semi-quantitative RT-PCR method as described previously
1 
using recombinant Taq DNA polymerase (Takara Taq; Takara 
Shuzo, Tokyo, Japan). UCP2 primers used were: 5’-GGCTGGTG-
GTGGTCGGAGAT-3’; 5’-CCGAAGGCAGAAGTGAAGTG-3.’
19 
PCR was conducted for 27 cycles for UCP2 and 25 cycles for 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH). The PCR 
products were analyzed by 1.2% agarose gel electrophoresis 
and stained with ethidium bromide. The PCR gel image was 
captured and analyzed using NIH image software. The data 
were expressed as a ratio of the measured calibrated mean pixel 
intensity of the UCP2 band to that of the corresponding GAPDH 
band.488  Gut and Liver, Vol. 5, No. 4, December 2011
6. Statistical analysis
All values were expressed as mean±standard error. Statistical 
analysis was performed using the Student’s t-test. A p-value of 
less than 0.05 was considered significant.
RESULTS
1. Hepatic injury after I/R
At 4 hours after reperfusion, serum ALT levels in the short 
ischemia group were significantly lower than those in the long 
ischemia group (p<0.05, Table 1). Fig. 1 shows representative 
pictures of H&E staining of ischemic lobes of both groups. In 
the short ischemia group, a relatively small amount of necrotic 
area was observed preferentially around periportal regions. Such 
changes were more pronounced and extended to pericentral 
regions in the long ischemia group. Nonischemic lobes main-
tained almost normal appearance in both groups.
2. Liver malondialdehyde concentrations after I/R
The hepatic MDA concentrations, a marker of hepatocel-
lular lipid peroxidation, were measured before and after I/R. 
As shown in Table 1, MDA concentrations increased after I/
R, and the increase in the ischemic lobes of the long ischemia 
group was significantly higher than in the short ischemia group 
(p<0.05). Although the differences were less pronounced, the 
increase was also observed in the nonischemic lobes of both 
groups, probably due to hyperperfusion during partial lober 
clamping.
20,21
3. Determination of UCP2 by semi-quantitative RT-PCR
To explore whether hepatic warm I/R induces changes in 
UCP2 mRNA levels, and whether any differences may occur 
according to degree of I/R injury, mRNA samples were col-
lected before ischemia and 4 hours after reperfusion and the 
expression of UCP2 mRNA levels were determined by semi-
quantitative RT-PCR method. In the ischemic lobes, the ex-
pression of UCP2 mRNA after I/R in the long ischemia group 
was significantly lower than that in the short ischemia group 
(p<0.01). Interestingly, UCP2 mRNA levels were increased even 
in nonischemic lobes of both groups with similar extent (Fig. 2).
4. Immunohistochemical examinations for UCP2
The localization of cells expressing UCP2 protein was ana-
lyzed by immunohistochemistry. It is known that UCP2 is ex-
pressed by macrophages in healthy liver. Before the treatment, 
the expression of UCP2 protein was not detected in hepatocyte, 
and only a small number of nonparenchymal cells had positive 
UCP2 immunoreactivity (data not shown). However, after 40 
minutes of ischemia followed by 4 hours of reperfusion, UCP2 
immunoreactivity was readily detected in the cytoplasm of 
hepatocytes. Furthermore, abundance of UCP2 expression dif-
Table 1. Serum ALT and MDA Levels in Liver Tissue before and after 
Ischemia-Reperfusion
Before 
ischemia
(n=8)
Sham 
operation
(n=8)
Short 
ischemia
(n=14)
Long 
ischemia
(n=14)
ALT*, IU/L 28±3 40±2 1,302±205
‡ 2,729±256
‡,§ 
MDA
†, nmol/mg protein
  Ischemic lobe
2.4±0.6 2.9±1.3
19.3±3.2
∥ 43.6±5.1
‡,§
  Nonischemic lobe 6.2±1.2 8.1±1.6
∥
*ALT, serum alanine aminotransferase levels at 4 hours after reperfu-
sion; 
†MDA, hepatic tissue levels of malondialdehyde at 4 hours after 
reperfusion; 
‡p<0.01 vs before ischemia; 
§p<0.05 vs short ischemia; 
∥p< 
0.05 vs before ischemia.
Fig. 1. Histopathologic findings at 4 hours after reperfusion (H&E stain, ×100). The livers of the long ischemia group showed multiple and exten-
sive areas of hepatocyte necrosis distributed through almost the entire intralobular zone (B), whereas the necrotic area in the short ischemia group 
was localized preferentially around the periportal region (A).Ninomiya M, et al: UCP2 and Hepatic Ischemia-Reperfusion  489
fered between the 2 groups. In short ischemia group, UCP2 was 
expressed almost the entire lobular area (Fig. 3A), whereas the 
liver of long ischemia group showed a small amount of UCP2 
positive hepatocytes (Fig. 3B). Interestingly, UCP2 protein was 
also detected even in nonischemic lobes after I/R (Fig. 3C, D). No 
significant changes in UCP2 immunoreactivity were observed in 
hepatocytes of sham operated animals (data not shown). UCP2 
immunoreactivity was scored as defined in Materials and Meth-
ods, and compared between the groups. In the ischemic lobes, 
the averaged score of the short ischemia group was significantly 
higher than that of the long ischemia group (2.2±0.1 and 1.3±0.1, 
respectively; p<0.01). The score in the nonischemic lobes was 
not significantly different (2.3±0.1 and 2.4±0.1, respectively). 
The necrotic area and immunoreactive area were quantitatively 
estimated for each groups at each intralobular zone and sum-
marized in Table 2. After I/R, UCP2 immunoreactivity was 
observed preferentially around the pericentral region (zone 3), 
while the necrotic area was more prominent around the peri-
portal (Zone 1) to mid-zonal region (Zone 2). Thus, intralobular 
distribution of UCP2 positive hepatocytes seemed to correlate 
inversely with that of necrotic area.
DISCUSSION
ROS generation is widely accepted as an important event in 
the pathogenesis of hepatic warm I/R injury. Previous reports 
revealed that not only Kupffer cells but also hepatocytes consti-
tute a major cellular component that displays oxidative changes 
after I/R.
3 Although hepatocytes of healthy rats do not express 
UCP2, when given bacterial lipopolysaccharide, UCP2 appears 
in hepatocytes via tumor necrosis factor-α (TNF-α) dependent 
mechanism.
22 In the present study, expression of UCP2 protein, 
which were defined to nonparenchymal cells at baseline, have 
been induced on cytoplasm of hepatocytes by warm I/R. It is not 
unreasonable to consider that UCP2 is induced by TNF-α, which 
is well known to be released into circulation after hepatic I/R.
23 
Induction of UCP2 protein in the nonischemic lobes supports 
the hypothesis that UCP2 is induced by soluble mediators after 
I/R. However, intralobular heterogeneity of UCP2 immunoreac-
tivity leads us to speculate the presence of another mechanism 
of inducing UCP2 after I/R. Yang et al.
13 have reported that a 
mitochondrial redox cycling agent that increases mitochondrial 
ROS production up-regulates UCP2 mRNA in primary cultures 
of normal rat hepatocytes. Considering the presence of intra-
lobular heterogeneity of oxidative stress,
24 it may be assumed 
that increases in oxidant production promoted the induction of 
UCP2 after I/R of the liver. As shown in Table 1, MDA concen-
trations increased after I/R. Even in the nonischemic lobes, MDA 
levels were increased after short and long ischemia and reperfu-
sion, although the increase was less pronounced as compared to 
the ischemic lobes. These results suggest that low levels of ROS 
generation had certainly occurred in the nonischemic lobes after 
I/R. ROS generation in the nonischemic lobes is supposed to be 
due to hyperperfusion during partial lobar clamping.
20,21
Comparing the 2 groups, a greater amount of UCP2 protein 
were expressed in the short ischemia group, in which less liver 
injury occurred, as indicated by the lower ALT levels in the se-
rum, and weaker histological damage. Furthermore, intralobular 
distribution of UCP2 positive hepatocytes tended to correlate 
inversely with that of necrotic area. After hepatic I/R, cellular 
damage is more prominent in Zone 1 as compared to Zone 3 
because the extent of oxidative stress is stronger in Zone 1 than 
in Zone 3.
24 Two possible explanations would be raised for the 
interpretation of these results. First, UCP2 had been up-regulat-
ed due to oxidant production after I/R, and inverse correlation 
between UCP2 expression and necrotic area may be the result 
of cytoprotective role of UCP2. Another possible explanation is 
that, although oxidative stress after I/R prompted the production 
of UCP2, loss of cellular viability secondary to severe damage 
due to I/R injury resulted in less expression of UCP2 around the 
necrotic area. 
Regarding the role of UCP2 in acute liver injury, Serviddio et 
al.
25 reported that, in NASH livers, UCP2 compromises the liver 
capacity to respond to acute energy demands after hepatic I/R 
Fig. 2. The expression of uncoupling protein-2 (UCP2) mRNA was 
determined after 40 (SI; short ischemia) or 90 (LI; long ischemia) 
minutes of ischemia followed by 4 hours of reperfusion using a semi-
quantitative reverse transcription-polymerase chain reaction method. 
(A) A representative photograph of UCP2 and glyceraldehyde 3-phos-
phate dehydrogenase (GAPDH) bands is shown. (B) The graph sum-
marizes the data from 8 to 14 rats per group. Values are expressed as 
relative intensity of the UCP2 band divided by the intensity of respec-
tive GAPDH band, as determined by densitometry. *p<0.01.490  Gut and Liver, Vol. 5, No. 4, December 2011
by depleting hepatic ATP content. On the other hand, Le Minh 
et al.
26 showed minimum relevance of UCP2 for the manifesta-
tion and extent of I/R injury in nondiseased livers. Thus, the 
role of UCP2 in hepatic I/R injury seems to differ according to 
underlying liver condition and ATP availability.
UCPs are thought to dissipate the proton gradient across the 
inner membrane of mitochondria, leading to production of heat 
without the phosphorylation of adenosine 5’-diphosphate. Ad-
ditionally, emerging evidence suggests that the up-regulation of 
mitochondrial UCPs may provide another means of constraining 
Fig. 3. Immunohistochemical evaluation of uncoupling protein-2 (UCP2) expression after 40 or 90 minutes of ischemia followed by 4 hours of 
reperfusion. The livers of the short ischemia group (A) accumulated much more UCP2 proteins than those of the long ischemia group (B). In the 
nonischemic lobes, both groups showed a similar degree of UCP2 expression levels after the treatment (C, short ischemia group; D, long ischemia 
group) (×100).
Table 2. Comparison of the Intralobular Distribution of UCP2-Positive Hepatocytes and Necrotic Lesions
UCP2 immunoreactivity Necrosis
Zone 1 Zone 2 Zone 3 Zone 1 Zone 2 Zone 3
Ischemic lobe
  Short ischemia
  Long ischemia
+
-
++
-
+++
+
+
+
+
++
-
+
Nonischemic lobe
  Short ischemia
  Long ischemia
-
-
+
+
++
++
-
-
-
-
-
-
-, 0-10%; +, 10-30%; ++, 30-60%; +++, >60%.Ninomiya M, et al: UCP2 and Hepatic Ischemia-Reperfusion  491
oxidant production during mitochondrial respiration.
11,27-29 Li 
et al.
30 reported that overexpression of UCP2 is associated with 
protection from ROS-induced toxicity in pancreatic β-cells. Giv-
en published evidence that UCP2 may decrease mitochondrial 
oxidant production in some cells, the results from present study 
suggest that UCP2 may be part of a negative feedback mecha-
nism by which mitochondrial ROS limit their own production. 
Moreover, considering the differences in UCP2 expression levels 
by the duration of ischemia and the presence of zone dependent 
UCP2 immunoreactivity, it is inferred that there may be a range 
in degree of oxidative stress in which UCP2 is induced. Namely, 
only relatively weak oxidative stress may be able to produce 
feedback signals to induce UCP2 on hepatocytes. The extent of 
oxidative stress in the periportal region is stronger than that 
of the pericentral region, and longer ischemic periods lead to a 
greater amount of oxidative stress.
24 These published evidences 
explain the intralobular heterogeneity and different levels of 
UCP2 expression between the 2 groups. Although a slight in-
crease in oxidative stress in the centrilobular region led to UCP2 
induction, stronger redox pressure around the periportal region 
overwhelmed the cellular protection system, and thus might 
have resulted in reduced levels of UCP2 expression. In the same 
way, shorter ischemic periods produced less oxidant stress with 
the consequence of much more UCP2 expression as compared 
to longer ischemia. Therefore, a moderate rather than a dramatic 
cytoprotective effect by UCP2 is speculated. UCP homologues 
form a subfamily that are evolutionarily related and can be 
identified even in plants, suggesting that UCPs emerged early 
during phylogenesis. Thus, UCPs might have played an im-
portant role in detoxifying relatively low levels of free radicals 
that can be generated in the normal physiological environment, 
such as infection or obesity,
17,22 rather than severe I/R injury. 
Therefore, the modulation of hepatic UCP2 expression would 
not be expected to serve as an effective therapeutic method for 
mitigating the hepatic I/R injury.
In summary, UCP2 are induced on hepatocytes after warm I/R 
of rat liver. Although the primitive role of UCP2 expression after 
oxidative stress may be cytoprotective one, an actual protective 
effect in hepatic I/R injury may be minimum.
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